MAGLEV Study - Research • Breast Cancer Foundation NZ


May 2016
Research Grant

What is the problem and who is affected?

Patients receiving oestrogen-suppressing drugs for breast cancer sometimes experience side effects related to cognitive function, including poor memory and inability to concentrate. These side effects can discourage women from completing their treatment, and could be due to low magnesium levels in the brain.

What is this research hoping to achieve?

Conducted by The University of Auckland, and open to patients in Auckland and Christchurch, MAGLEV is a pilot study investigating whether taking a magnesium supplement reduces memory and concentration issues caused by hormone therapy commonly used in breast cancer treatment.

A finding that some women benefit from this simple remedy would have enormous global impact.